AbbVie Inc.
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Women on the Board of Directors by Year
Women on the Board of Directors (%) (%)
AbbVie Women on the Board of Directors: 38.0% in FY2025, up 2.0 pts from a year earlier.
Latest, FY2025
38.0%
Period ended Dec 31, 2025
Change on a year earlier
+2.0 pts
36.0% in FY2024
History
4 years
Since FY2022
Sources
3
Documents cited below
Where the FY2025 figure comes from
“Employee Demographic Metrics Introduction Total employees17 Gender Diversity in U.S. Representation18 Gender Representation18 Total Workforce (%)18 Board of Directors Executive and Board Positions19 VP Positions 0% ~53,000 ~55,000 ~57,000 Patients 38% 44% 45% 45% 56% 40% U.S. Employees Who 62% 55% 55% Are Members of Women 2023 2024 2025 Underrepresented Men Populations Our People Other Gender Top Management Positions21 Director Positions Manager Positions and Culture 38% U.S. Workforce by Race and Ethnicity18 48% 45% 52% 55% Share in Total Workforce Share in all management 62% (as % of total workforce) 20% positions20 (manager level and above as % of total management workforce) 2% U.S. Employees Business Sustainability 3% Management Positions in 2% Who Are Veterans Revenue-Generating Functions22 Professional Positions23 STEM-related Positions24 7% 61% 10% 25% 44% 43% 42% 60% 56% 57% 58% 5% 3% 6% Asian Black or African American Hispanic/Latinx White U.S. Employees Who Other (Includes Native American/Alaska Native, Native Have Disabilities Women Men Other Gender Hawaiian/Other Pacific Islander and Two or More Races)”
Source: AbbVie 2025 ESG Action Report ↗
Reported in AbbVie ESG Action Reports.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Women on the Board of Directors (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 38.0% | +2.0 pts | AbbVie 2025 ESG Action Report ↗ |
| FY2024 | Dec 31, 2024 | 36.0% | -2.0 pts | AbbVie 2024 ESG Action Report ↗ |
| FY2023 | Dec 31, 2023 | 38.0% | +11.0 pts | AbbVie 2023 ESG Action Report ↗ |
| FY2022 | Dec 31, 2022 | 27.0% | – | AbbVie 2023 ESG Action Report ↗ |
Cite this data
StockData. (2026). AbbVie Women on the Board of Directors (%), annual FY2022–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/esg-women-board
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.